2026-05-27T13:10:48-07:00 2025-12-31 320285866 MARK R OLHOEFT CPA 31103 Rancho Viejo Rd D-3187 SAN JUAN CAPISTRANO CA 92675 990 2025-01-01 993637100 Institute For Evolvable Medicines INST 5103164205 11 Embarcadero West 140 Oakland CA 94607 Galyn Susman Treasurer 2026-05-27 true Mark R Olhoeft CPA P00128288 9494890136 X 2025 2025-03-06 01:10:19Z 11 Embarcadero West 140 Oakland CA 94607 908805 false X www.evorx.org X 2024 CA The specific purpose of this corporation is to research and develop a completely new class of 'evolvable' medicines 7 0 0 0 906776 0 2029 0 908805 0 0 98309 0 0 495919 594228 314577 4424 1377529 0 4424 1377529 The specific purpose of this corporation is to research and develop a completely new class of 'evolvable' medicines false false 450493 The Institute for Evolvable Medicines develops next-generation therapeutics designed to adapt and evolve within the body to combat rapidly mutating diseases, including cancer, viruses, and antibiotic-resistant bacteria. The organizations work focuses on advancing biologically based medicines through preclinical research, manufacturing, and regulatory preparation toward human clinical trials.Patients with life-threatening diseases; research activities conducted in the United States.In 2025, the organization advanced its lead therapeutic candidate, EM0924, through preclinical development. Activities included manufacturing process development, analytical development, nonclinical testing, and preparation for regulatory submission of an Investigational New Drug (IND) application. 450493 true false false false false false false false false false false false false false false false false false false false false false false false false false false false false true false false false false false false false false false false false false false false false false false true 0 0 false 0 false false false false false false false 0 false false false false false false false X 7 0 false false false false false false false false false false false false false false false false false false Galyn Susman 5103164205 11 Embarcadero West 140 Oakland CA 94607 Leor Weinberger CEO 8.00 0.00 X X 151921 0 0 Galyn Susman Secretary-CFO 8.00 0.00 X X 88461 0 0 Brian Kaye Treasurer 1.00 0.00 X 0 0 0 Nancy Halgwood Director 1.00 0.00 X 0 0 0 Stuart Tyner Director 1.00 0.00 X 0 0 0 David J Bacon Director 1.00 0.00 X 0 0 0 Wendy Sammons-Jackson Director 1.00 0.00 X 0 0 0 240382 1 false true false 0 906776 906776 0 2029 2029 0 0 0 0 0 0 0 0 908805 2029 0 0 0 0 88461 88461 0 0 0 0 9848 9848 0 42542 42542 968 968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 530 530 Contractors 450493 450493 Software and Subscriptions 1316 1316 Bank Fees 94 94 Licenses and Permits 25 25 -49 -49 594228 450493 143735 0 4424 318938 0 1058591 0 0 0 0 0 0 0 0 0 0 0 0 4424 1377529 0 0 X 4424 1377529 4424 1377529 4424 1377529 X 314577 1058528 X false false false X 4500 906776 911276 0 0 4500 906776 911276 0 911276 0 0 0 911276 X 0.00000 false false false false false false false false false Leor Weinberger CEO Form 990, Part VI, Section B, Line 11b No review was or will be conducted. Form 990, Part VI, Section C, Line 19 No documents available to the public. Form 990, Part XI, Line 9 Grants Receivable - Book / Tax Reconciliation = $1058528